SAB Biotherapeutics Ratios (2020-2025) | SABS

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 8.33%-16.15%-27.66%-104.46%9.13%-76.66%-197.12%-363.23%-1,265.50%-8,046.13%-402.59%-7,493.75%-532.06%-2,787.69%13,262.35%-8,669.15%15,495.10%15,203.74%27,873.57%
EBIT Margin 4.81%-15.77%-27.18%-66.41%-56.83%-103.03%-217.49%-363.74%-1,273.79%-7,573.40%-420.00%-6,187.90%-1,205.90%-3,876.95%14,492.50%-8,726.26%15,484.95%15,124.81%29,287.09%
EBITDA Margin 4.81%-15.77%-27.18%-66.41%-56.83%-103.03%-217.49%-363.74%-1,273.79%-7,573.40%-420.00%-6,187.90%-1,205.90%-3,876.95%14,492.50%-8,726.26%15,484.95%15,124.81%29,287.09%
Operating Margin 4.81%-15.77%-27.18%-66.41%-56.83%-103.03%-217.49%-363.74%-1,273.79%-7,573.40%-420.00%-6,187.90%-1,205.90%-3,876.95%14,492.50%-8,726.26%15,484.95%15,124.81%29,287.09%
Net Margin 8.33%-16.15%-27.66%-104.46%8.35%-75.21%-197.12%-364.42%-1,265.50%-8,046.13%-402.59%-7,493.75%-532.06%-2,787.69%13,262.35%-9,934.52%7,470.38%15,718.81%27,873.57%
FCF Margin 44.68%-54.09%3.88%-65.47%-92.31%-79.69%-222.78%-77.41%-279.99%-5,755.33%-414.49%-4,430.85%-1,151.74%-2,952.95%8,191.52%-8,358.96%11,208.53%11,114.37%30,144.19%
Efficiency
Assets Average 86.91M117.18M117.01M99.03M74.81M63.95M55.96M51.71M46.79M39.06M31.89M56.14M77.66M66.63M57.84M49.00M41.16M34.12M106.79M
Equity Average 39.89M39.51M36.67M36.81M39.90M39.19M33.87M30.84M27.73M22.06M17.49M36.28M55.06M49.47M41.51M31.44M23.69M16.71M88.55M
Invested Capital 39.01M40.77M38.26M35.08M42.47M41.26M37.12M30.62M34.82M28.13M23.33M15.26M57.30M52.82M46.12M36.90M25.97M21.41M12.02M165.07M
Asset Utilization Ratio 0.610.750.690.590.460.270.160.130.040.030.040.020.030.010.000.00
Leverage & Solvency
Interest Coverage Ratio 10.82-38.59-50.80-110.81-93.13-91.85-110.54-89.62-80.12-85.99-76.37-242.35-149.15-109.56-144.92-141.22-154.85-151.25-292.87
Debt to Equity 0.000.02
Debt Ratio 0.000.01
Equity Ratio 0.690.350.330.300.480.600.620.580.610.570.560.540.680.740.750.690.590.560.400.90
Times Interest Earned 10.82-38.59-50.80-110.81-93.13-91.85-110.54-89.62-80.12-85.99-76.37-242.35-149.15-109.56-144.92-141.22-154.85-151.25-292.87
Valuation
Enterprise Value 427.24M106.38M137.13M431.73M299.99M139.10M45.68M21.83M10.34M5.87M34.06M30.54M-20.60M-2.17M-8.72M-5.51M14.26M-0.22M10.59M-89.95M
Market Capitalization 439.85M126.50M147.37M442.48M339.54M161.51M62.30M30.16M25.38M18.93M41.83M32.96M35.97M41.88M28.61M24.92M35.02M12.63M16.31M20.93M
Return Ratios
Return on Sales -0.28%-0.32%-0.44%-0.68%-0.78%-2.13%-4.54%-6.64%-18.85%-15.32%-14.50%-31.76%-26.24%-166.82%420.11%681.11%
Return on Capital Employed -0.18%-0.38%-0.52%-0.73%-0.79%-0.89%-1.05%-1.19%-0.84%-0.61%-0.78%-1.06%-1.05%-1.34%-1.78%-0.45%
Return on Assets -0.17%-0.23%-0.30%-0.40%-0.36%-0.58%-0.75%-0.85%-0.75%-0.51%-0.61%-0.79%-0.67%-0.93%-1.20%-0.40%
Return on Equity -0.47%-0.44%-0.50%-0.66%-0.61%-0.98%-1.32%-1.55%-1.16%-0.72%-0.82%-1.10%-1.04%-1.62%-2.44%-0.48%